SonoRobotics is an ETH Zurich spin-off developing innovative catheters for rapid thrombus disruption and microvascular protection in PCI.

SonoRobotics is an ETH Zurich spin-off developing innovative catheters for rapid thrombus disruption and microvascular protection in PCI.

Team

Team

Team

Daniel Ahmed

Founder, CEO

Founder, CEO

Daniel Ahmed leads the company’s scientific and strategic development. With over 20 years of experience in ultrasound technologies, he has driven advances in ultrasound-based manipulation, robotics, and microtechnologies, with work published in Nature, Science Robotics, Nature Electronics, Nature Machine Intelligence, and other leading journals. He has secured funding through competitive European and Swiss programs, including ERC, SNSF, BRIDGE, and EIC awards. Daniel is the recipient of the Falling Walls Science Breakthrough of the Year 2021 in Engineering & Technology, the ETH Zurich Dandelion Entrepreneurship Award, and a DWI Fellowship at Aachen University. He is Associate Professor at the ARTORG Center, University of Bern, and was previously Assistant Professor of Acoustic Robotics at ETH Zurich.

Author Image

Author Image

Anil Sethi

Co-founder, CBO

Co-founder, CBO

Anil Sethi, Chief Business Officer, leads business development and commercialization. A serial entrepreneur and Entrepreneur-in-Residence at ETH Zurich, he has founded and scaled multiple startups, including ETH spin-off Flisom, where he served as CEO and CFO and helped raise over CHF 100 million before a successful exit. He has taught entrepreneurship at ETH Zurich for many years, mentored numerous founders, and is the author of From Science to Startup and From Startup to Unicorn. He strengthens the company’s commercial strategy, business development, and financing capabilities.

Advisory Board

Advisory Board

Advisory Board

Author Image

Author Image

Dr. Jurjen Zoethout

Regulatory Advisor

Regulatory Advisor

Dr. Jurjen Zoethout advises the company on FDA and EU regulatory strategy. With over 25 years of experience in MedTech, he is an expert in regulatory, quality, and clinical affairs, with a strong track record of guiding companies through complex US and European approval pathways, enabling compliant product launches, and managing interactions with regulatory authorities. He has coached numerous startups, co-founded three innovation-driven companies, and supported the growth of multiple MedTech ventures.

Author Image

Author Image

Prof. Dr. med. Lorenz Räber

Clinical Advisor

Clinical Advisor

Prof. Dr. med. Dr. phil. nat. Lorenz Räber advises the company on clinical strategy, validation, and adoption in interventional cardiology. He is Senior Physician at Bern University Hospital, Director of the Cardiac Catheterization Laboratory, Head of Coronary Heart Disease and Myocardial Infarction at Inselspital, and since 2024 Vice-President of the Swiss Society of Cardiology. A leading interventional cardiologist, he has helped shape the field through major clinical and imaging studies, including the PACMAN-AMI trial published in JAMA, and received the 2023 Research Prize of the Swiss Heart Foundation.